Back

Cardiovascular risk profiling in allogenic hematopoietic stem cell transplantation survivors

31 August 2025 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Cardio-oncology challenges Stratification, Prevention and Monitoring ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Mikko Emilio Mutti

Cardiovascular Research Institute Basel, Basel (Switzerland)

4 More presentations in this session

Presentation thumbnail
MyD-88/NLRP-3 inhibition by dapagliflozin protects against anthracycline and trastuzumab cardiotoxicity in preclinical models
Doctor N. Maurea (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Biomarker and imaging characterisation of inflammatory atheroma in patients receiving immunotherapy and angiogenesis inhibitors (BIOCAPRI): a prospective study using positron emission tomography
Doctor S. Rankin (Glasgow, GB)
Abstract Slides Video
Presentation thumbnail
Predicting Cardiovascular Risk in Patients with Prostate Cancer Receiving Abiraterone or Enzalutamide by Using Machine Learning
Doctor D. Chen (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Surveillance of left ventricular function among asymptomatic cancer survivors
Doctor C. Soh (Melbourne, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Cardio-oncology challenges

The Event

Event poster

ESC Congress 2025

31 August 2025 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular events and consequent risk of death in hematopoietic stem cell transplant recipients
thumbnail
Congress Presentation
Incidence of atrial fibrillation after haematopoietic stem cell transplantation: the COAST-AF study
thumbnail
Congress Presentation
Sex differences in cardiovascular complications after allogeneic hematopoietic stem cell transplantation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources